The biochemist introduced the first heel-prick tests for newborn babies in Spain, protecting infants from life-changing ...

PTC Therapeutics (PTCT) is advancing 8% after investment bank Cantor Fitzgerald’ hiked its price target on the drug maker’s ...

SEMINOLE, Fla. (WFLA) — A Pinellas County mother is in a desperate fight to keep her 4-year-old son healthy. Gideon Bennett ...

A Pinellas County mother is in a desperate fight to keep her 4-year-old son healthy. Gideon Bennett has a rare genetic ...

A Seminole mom is fighting for her son’s health after a rare disorder left him dependent on a strict medical diet. But now, she’s facing an unexpected challenge: losing access to the ...

ACTIVATE-Kids is the First Study to Demonstrate Efficacy of an Oral Therapy for Children with PK Deficiency Who Are Not Regularly Transfused –– ...

The offerings reflect an increase in IPO activity that could continue, as four other biotechs recently outlined plans to go ...

Introduction to Newborn Screening InstrumentsNewborn screening is a critical medical process that involves testing newborns for certain genetic, metabolic, and congenital conditions. The objective is ...

PTC Therapeutics (PTCT) saw its shares surge in the last session with trading volume being higher than average. The latest ...

Research and Development (R&D) Expenses: R&D expenses were $82.8 million for the fourth quarter of 2024, compared to $77.5 million for the fourth quarter of 2023, and $301.3 million for the full year ...

Synthetic biology specialist Synlogic will start phase 3 testing of a drug for rare metabolic disorder phenylketonuria (PKU) next year, after reporting solid proof-of-concept data.

Kiesel was a political commentator on KOSU’s weekly radio program and podcast This Week in Oklahoma Politics for 13 years.